Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06299384 · ClinicalTrials.gov registry record · NA
The Use of Voice-Based AI in 988 Crisis Counseling
A NA study of Suicide and Suicide and Self-harm, sponsored by Lyssn.io.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06299384: Recruiting NA study of Suicide and Suicide and Self-harm, sponsored by Lyssn.io.
NCT06299384 is a NA study of Suicide and Suicide and Self-harm that is actively recruiting participants, run by Lyssn.io. The registered enrollment target is 50 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06299384, a NA study of Suicide and Suicide and Self-harm, is actively recruiting participants, sponsored by Lyssn.io.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Effective training requires repeated opportunities for skills practice with performance-based feedback, which is challenging to provide at scale. This research study focuses on developing an AI-based, coding and feedback tool ("LyssnCrisis") for implementation in a nationally utilized crisis call center, training counselors (call-takers) in suicide risk assessment skills, and evaluating LyssnCrisis to improve services and client outcomes. This research study's goal is to maximize the human capacity of call-takers to help assess their callers for risk of suicidality, and thus, a core aspect of the current research is developing a novel training process that supports human call-taker capacities.
Primary Outcome
9 item survey utilizing LifeLine crisis call questions that measures changes in distress, perceived helpfulness, and call-taker relationship at the conclusion of a crisis call. The survey is completed by callers to ProtoCall's 988 crisis line, facilitated by the call-taker. .
Conditions Studied
Interventions
- OTHER LyssnCrisis
Study Locations (1)
Oregon
- ProtoCall Services, Inc. - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-02 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06299384 shows while recruiting
NCT06299384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which LyssnCrisis is the first listed.
NCT06299384 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06299384 about?
NCT06299384 is a clinical study titled "The Use of Voice-Based AI in 988 Crisis Counseling". Effective training requires repeated opportunities for skills practice with performance-based feedback, which is challenging to provide at scale. This research study focuses on developing an AI-based, coding and feedback tool ("LyssnCrisis") for implementation in a nationally utilized crisis call ce...
What is the current status of trial NCT06299384?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-02. Estimated completion is 2026-08.
What conditions does trial NCT06299384 study?
This clinical trial studies the following conditions: Suicide, Suicide and Self-harm.
What interventions are being tested in trial NCT06299384?
The interventions under investigation include: LyssnCrisis (OTHER).
Who is sponsoring clinical trial NCT06299384?
This trial is sponsored by Lyssn.io, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06299384 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06299384's enrollment target sits among peer trials
50 72nd of 92 higher than 17 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI